Image source, AFP via Getty ImagesImage caption, The Trump administration linked use of Tylenol during pregnancy to autism, despite what scientists say is inconclusive evidenceByNatalie ShermanBusiness reporterPublished3 November 2025 Kimberly-Clark is set to buy Kenvue, the maker of Tylenol, which has faced attacks from the White House and flagging demand for its products. The more-than $40bn (£30.5bn) cash-and-stock deal would create a consumer giant, with a portfolio of some of the world's most commonly stocked bathroom and medicine cabinet items. Kimberly-Clark makes Kleenex, Huggies nappies and some of the biggest toilet paper brands in the US. As well as Tylenol, Kenvue is known for Band-Aid, Zyrtec, Benadryl, Neutrogena and Aveeno. Both firms have been under pressure as price-conscious households increasingly turn to cheaper, store-brand versions of their products. Johnson & Johnson spun off Kenvue as a standalone company in 2023, separating its faster growing, more profitable medical technical and pharmaceutical business from its consumer products.
Published: November 3, 2025 3:55 pm
Source: BBC — Read original